CRIS Current Research Information System

GALVANI, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.947
EU - Europa 1.339
NA - Nord America 1.320
AF - Africa 155
SA - Sud America 71
OC - Oceania 1
Totale 4.833
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.284
VN - Vietnam 707
IT - Italia 700
SG - Singapore 422
CN - Cina 359
HK - Hong Kong 139
GB - Regno Unito 131
DE - Germania 119
NL - Olanda 84
FR - Francia 73
BD - Bangladesh 67
BR - Brasile 56
IN - India 49
KR - Corea 48
FI - Finlandia 40
SC - Seychelles 40
CI - Costa d'Avorio 39
IE - Irlanda 34
JP - Giappone 34
SE - Svezia 31
TG - Togo 30
ZA - Sudafrica 28
CA - Canada 24
ES - Italia 22
CH - Svizzera 21
RU - Federazione Russa 20
TH - Thailandia 20
PH - Filippine 18
BG - Bulgaria 16
AT - Austria 13
ID - Indonesia 13
JO - Giordania 13
PL - Polonia 13
PK - Pakistan 12
TR - Turchia 11
MX - Messico 10
TW - Taiwan 10
BE - Belgio 5
AE - Emirati Arabi Uniti 4
AR - Argentina 4
EG - Egitto 3
HR - Croazia 3
IQ - Iraq 3
IR - Iran 3
MA - Marocco 3
MY - Malesia 3
NG - Nigeria 3
PE - Perù 3
UZ - Uzbekistan 3
CL - Cile 2
CO - Colombia 2
DZ - Algeria 2
EC - Ecuador 2
GH - Ghana 2
HN - Honduras 2
LT - Lituania 2
PT - Portogallo 2
RO - Romania 2
TN - Tunisia 2
AM - Armenia 1
AU - Australia 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GE - Georgia 1
GR - Grecia 1
IS - Islanda 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
LY - Libia 1
MM - Myanmar 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
Totale 4.833
Salva come PNG Salva come JPEG
Città #
Singapore 336
Bologna 224
Ho Chi Minh City 193
Ashburn 174
Hanoi 158
San Jose 124
Hong Kong 117
Chandler 106
Hefei 106
Boardman 68
Council Bluffs 49
Dallas 46
Bristol 45
Seoul 43
Fairfield 42
Frankfurt am Main 40
Santa Clara 40
Abidjan 39
Los Angeles 39
Helsinki 36
New York 34
Southend 34
Dublin 33
Lomé 30
Beijing 29
Islington 29
Lauterbourg 29
Redmond 29
Trento 29
Ann Arbor 27
Da Nang 27
Dong Ket 26
Milan 25
Tokyo 25
Haiphong 24
Johannesburg 23
Turin 22
Amsterdam 20
Munich 18
Princeton 18
Houston 17
Marano 16
Sofia 16
Bern 15
Jerez De La Frontera 15
Modena 15
Amman 13
Argelato 13
Rimini 12
Buffalo 11
Florence 11
Paris 11
Rome 11
Seattle 11
Vienna 11
Wilmington 11
Cambridge 10
Chicago 10
Forlì 10
Hải Dương 10
Jakarta 10
Nha Trang 10
San Diego 10
São Paulo 10
Woodbridge 10
Bengaluru 9
Berlin 9
Bolzano 9
Warsaw 9
Imola 8
Parma 8
Redondo Beach 8
Toronto 8
Bangkok 7
Biên Hòa 7
Castel Maggiore 7
Des Moines 7
Long Xuyen 7
Điện Bàn 7
Bari 6
Can Tho 6
Cesena 6
Medford 6
Montreal 6
Orem 6
Polinago 6
Quận Một 6
Shanghai 6
Shenzhen 6
Brussels 5
Bắc Giang 5
Cao Lanh 5
Changsha 5
Genoa 5
Lahore 5
Naples 5
Palermo 5
Phoenix 5
Phủ Lý 5
Pune 5
Totale 3.080
Salva come PNG Salva come JPEG
Nome #
Inhibition of microglia over-activation restores neuronal survival and maturation in a mouse model of CDKL5 deficiency disorder 398
Age-related cognitive and motor decline in a mouse model of CDKL5 deficiency disorder is associated with increased neuronal senescence and death 349
A GABAB receptor antagonist rescues functional and structural impairments in the perirhinal cortex of a mouse model of CDKL5 deficiency disorder 295
Luteolin Treatment Ameliorates Brain Development and Behavioral Performance in a Mouse Model of CDKL5 Deficiency Disorder 293
Gut Microbiome Modulation in Hepatocellular Carcinoma: Preventive Role in NAFLD/NASH Progression and Potential Applications in Immunotherapy-Based Strategies 282
Expression of a Secretable, Cell-Penetrating CDKL5 Protein Enhances the Efficacy of Gene Therapy for CDKL5 Deficiency Disorder 255
Inhibition of microglia overactivation restores neuronal survival in a mouse model of CDKL5 deficiency disorder 252
CDKL5 deficiency predisposes neurons to cell death through the deregulation of SMAD3 signaling (vol 29, pg 658, 2019) 250
MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma 243
Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of CDKL5 Deficiency Disorder 243
Increased DNA Damage and Apoptosis in CDKL5-Deficient Neurons 242
MiR-22/GLUT1 Axis Induces Metabolic Reprogramming and Sorafenib Resistance in Hepatocellular Carcinoma 221
Functional and structural impairments in the perirhinal cortex of a mouse model of CDKL5 deficiency disorder are rescued by a TrkB agonist 210
Pharmacotherapy with sertraline rescues brain development and behavior in a mouse model of CDKL5 deficiency disorder 204
Noncoding RNAs in Hepatocellular Carcinoma: Potential Applications in Combined Therapeutic Strategies and Promising Candidates of Treatment Response 187
Mir-30e-3p/CXCL3 axis is involved in sorafenib resistance of hepatocellular carcinoma through the modulation of the tumor immune microenvironment 106
Gut microbiome alterations and lenvatinib resistance in hepatocellular carcinoma: the role of Akkermansia muciniphila postbiotics in treatment enhancement 94
miR-30e-3p/CXCL3 axis predicts early tumor escape in sorafenib-treated hepatocellular carcinoma patients. 88
miR-30e-3p/CXCL3 axis predicts early tumor escape in hepatocellular carcinoma patients undergoing sorafenib treatment 74
Towards precision medicine: a preliminary collection of patient-derived organoids for the screening of personalised therapies in hepatocellular carcinoma 72
MiR-22-3p targets the G2/M checkpoint inhibitor Wee1 and represents a possible biomarker of TACE response in hepatocellular carcinoma 71
MiR-494 induces metabolic reprogramming through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma 70
The tumour suppressor miR-22 induces metabolic reprogramming through GLUT1 targeting and represents a possible biomarker of Sorafenib response in Hepatocellular Carcinoma 66
MiR-22 downregulation activates HIF-1A pathway and induces tumour progression, metabolic reprogramming and sorafenib resistance in hepatocellular carcinoma 63
miR-30e-3p/CXCL3 axis predicts early tumor escape in sorafenib-treated HCC patients. 62
MiR-494 induces metabolic reprogramming through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma 59
CXCL3 is a target of miR-30e-3p and predicts tumor escape in sorafenib-treated HCC patients. 58
MiR-22 regulates HIF-1A pathway and tumor progression and represents a possible biomarker of sorafenib response in hepatocellular carcinoma 51
MiR-30e-3p plays a dual role in hepatocellular carcinoma and predicts tumour escape to sorafenib Treatment 49
Circulating miR-22 Early Predicts TACE Non-Response and Targets WEE1 in Hepatocellular Carcinoma 18
Totale 4.925
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.468
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.468
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202131 0 0 0 0 0 0 0 0 0 0 0 31
2021/2022332 28 18 28 37 20 13 18 18 17 25 62 48
2022/2023589 31 78 36 45 65 56 24 57 95 14 49 39
2023/2024291 9 21 4 29 12 51 42 40 32 12 13 26
2024/2025627 51 64 57 50 45 29 58 29 18 86 61 79
2025/20262.912 205 344 162 129 155 193 395 149 632 161 162 225
Totale 4.925